SCHEMBL3432137

SCHEMBL3432137

COC(=O)/C=C/c1ccc(C2CCCN2CCn2ccc(C)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 5/20 0.50
▸ KCNH2 Q12809 1/20 0.45
▸ HTT P42858 1/20 0.39
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ TYR P14679 1/20 0.38
▸ CA7 P43166 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ CA14 Q9ULX7 1/20 0.38
▸ OPRM1 P35372 1/20 0.37
▸ OPRK1 P41145 1/20 0.37
▸ KDM1A O60341 2/20 0.37
▸ ATM Q13315 1/20 0.35
▸ PTPN1 P18031 1/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ ADORA2B P29275 1/20 0.34
▸ HDAC8 Q9BY41 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1780449 1.00 HDAC1 (0.50) HDAC1KCNH2HTTCA12CA1
SCHEMBL1780445 1.00 HDAC1 (0.50) HDAC1KCNH2HTTCA12CA1
SCHEMBL1780451 1.00 HDAC1 (0.50) HDAC1KCNH2HTTCA12CA1
SCHEMBL1777283 0.89 HDAC1 (0.62) HDAC1KCNH2KDM1AHDAC8HDAC6
SCHEMBL1780069 0.89 HDAC1 (0.62) HDAC1KCNH2KDM1AHDAC8HDAC6
SCHEMBL1777279 0.89 HDAC1 (0.62) HDAC1KCNH2KDM1AHDAC8HDAC6
SCHEMBL1777282 0.89 HDAC1 (0.62) HDAC1KCNH2KDM1AHDAC8HDAC6
SCHEMBL1780100 0.87 HDAC1 (0.46) HDAC1KCNH2HTTCA12CA1
SCHEMBL1780097 0.87 HDAC1 (0.46) HDAC1KCNH2HTTCA12CA1
SCHEMBL3432931 0.87 HDAC1 (0.46) HDAC1KCNH2HTTCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2260020-A1 HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES B Novartis AG (CH) 2010-12-15 — — EP disclosed
WO-2009118305-A1 HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES B NOVARTIS AG (CH) 2009-10-01 — — WO disclosed
Send feedback